Latest News

March 19, 2010
The UCSF School of Pharmacy is charting new territory with an interdisciplinary education program for health care professionals on Medicare Part D.
March 18, 2010
Taking an innovative path toward personalized medicine, scientists for the first time will be able to eliminate – at an early point in a clinical trial — experimental drugs that show poor efficacy, dramatically shortening the time it takes to get the right medication to the right patient with breast cancer.
March 17, 2010
Banned chemicals -- present in amounts higher than levels found in recent years in US adults -- are turning up in the blood of young girls being studied in California and Ohio. Robert Hiatt
March 16, 2010
UCSF researchers have discovered that a key cellular defect that disturbs the production of proteins in human cells can lead to cancer susceptibility. The scientists also found that a new generation of inhibitory drugs offers promise in correcting this defect.
March 11, 2010
UCSF scientists have discovered how a mutated gene known as Kras is able to hijack mouse cells damaged by acute pancreatitis, putting them on the path to becoming pancreatic cancer cells.
March 11, 2010
People are paying close attention to pediatric endocrinologist Robert Lustig’s message that the obesity epidemic can be blamed on a marked increase in the consumption of a type of sugar called fructose.
March 08, 2010
Doctors treat millions of children with Ritalin every year to improve their ability to focus on tasks, but scientists now report that Ritalin also directly enhances the speed of learning.
March 08, 2010
Stem cells derived from adult tissues differ from embryonic stem cells, researchers find.
March 03, 2010
A new study co-authored by a UCSF resident physician and published this week examines why low-income countries are making poor progress in meeting international health goals. Study researcher Sanjay Basu, MD, PhD, of the Department of Medicine at UCSF and Division of General Internal Medicine at San Francisco General Hospital, said findings highlight the importance of looking at the entire health experience of a family, rather than just one or a few diseases.
March 03, 2010
New UCSF clinical trial tests intermittent high-dosage treatment for HER2-positive breast cancers.

Pages